Organon & Co. Investors: Please contact the Portnoy Law Firm to recover your losses. July 22, 2025 Deadline to file Lead Plaintiff Motion

Core Viewpoint - A class action lawsuit has been initiated against Organon & Co. for allegedly misleading investors regarding its capital allocation strategy and dividend policies during the specified Class Period from October 31, 2024, to April 30, 2025 [1][3]. Group 1: Allegations and Financial Impact - The lawsuit claims that Organon concealed critical information about its capital allocation strategy, particularly regarding its quarterly dividend payout [3]. - Despite public statements emphasizing the dividend as the company's "number one priority," Organon had adopted a debt reduction strategy that conflicted with maintaining the dividend [3]. - Following the acquisition of Dermavant Sciences Ltd., Organon intended to shift its capital priorities towards debt reduction, which led to a significant cut in the dividend [3]. - On May 1, 2025, Organon announced a drastic reduction in its quarterly dividend from $0.28 to $0.02 per share, resulting in a stock decline of over 27% [4].